Literature DB >> 34953761

Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk.

Duaa S Nasereldin1, Launia J White2, David O Hodge2, Lewis R Roberts3, Tushar Patel4, Samuel O Antwi5.   

Abstract

BACKGROUND: The obesity and hepatocellular carcinoma (HCC) risk association may differ by individuals' metabolic health status. AIM: To investigate the association between obesity categories and HCC risk among individuals with different metabolic health phenotypes.
METHODS: A case-control study among 518 HCC cases and 1,036 frequency-matched controls was conducted. Body mass index (BMI) was assessed before diagnosis. Pre-diagnosis data on dyslipidemia, hypertension, and diabetes were used to categorize participants as metabolically healthy or metabolically unhealthy. Participants were further categorized into metabolically healthy normal weight (MHNW), metabolically healthy overweight (MHOW), metabolically healthy obese (MHO), metabolically unhealthy normal weight (MUNW), metabolically unhealthy overweight (MUOW), and metabolically unhealthy obese (MHO). We used logistic regression to calculate multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Being overweight (OR=1.68, 95%CI=1.21-2.34) or obese (OR=1.49, 95%CI=1.11-1.89) was associated with higher HCC risk. Among metabolically healthy participants, no association was found between being overweight or obese and HCC risk. However, among the metabolically unhealthy participants, being overweight (OR=1.89, 95%CI=1.31-2.72) or obese (OR=1.50, 95%CI=1.07-2.09) was associated with higher HCC risk. Compared to the MHNW phenotype, no association was found between the MHOW and MHO phenotypes and HCC risk, but the MUNW (OR=1.94, 95%CI=1.09-3.43), MUOW (OR=3.78, 95%CI=2.15-6.65), and MUO (OR=2.93, 95%CI=1.70-5.05) phenotypes were associated with higher HCC risk.
CONCLUSION: The association between BMI and HCC appears to be restricted to individuals with underlying metabolic abnormalities.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  BMI; HCC; Hepatocellular carcinoma; Liver cancer; Metabolic; obesity

Mesh:

Year:  2021        PMID: 34953761      PMCID: PMC9213572          DOI: 10.1016/j.dld.2021.12.002

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   5.165


  46 in total

1.  Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP).

Authors:  Walter A Rocca; Brandon R Grossardt; Scott M Brue; Cynthia M Bock-Goodner; Alanna M Chamberlain; Patrick M Wilson; Lila J Finney Rutten; Jennifer L St Sauver
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

Review 2.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021.

Authors: 
Journal:  Diabetes Care       Date:  2021-01       Impact factor: 19.112

3.  Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C.

Authors:  Samuel O Antwi; Holly K Van Houten; Lindsey R Sangaralingham; Tushar Patel
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-26

Review 4.  Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms.

Authors:  Ali Fatehi Hassanabad
Journal:  Transl Lung Cancer Res       Date:  2019-10

5.  Identification and characterization of metabolically benign obesity in humans.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Kilian Rittig; Bernd Balletshofer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Arch Intern Med       Date:  2008-08-11

6.  Human metabolic phenotype diversity and its association with diet and blood pressure.

Authors:  Elaine Holmes; Ruey Leng Loo; Jeremiah Stamler; Magda Bictash; Ivan K S Yap; Queenie Chan; Tim Ebbels; Maria De Iorio; Ian J Brown; Kirill A Veselkov; Martha L Daviglus; Hugo Kesteloot; Hirotsugu Ueshima; Liancheng Zhao; Jeremy K Nicholson; Paul Elliott
Journal:  Nature       Date:  2008-04-20       Impact factor: 49.962

7.  Prediabetes and the risk of cancer: a meta-analysis.

Authors:  Yi Huang; Xiaoyan Cai; Miaozhen Qiu; Peisong Chen; Hongfeng Tang; Yunzhao Hu; Yuli Huang
Journal:  Diabetologia       Date:  2014-09-11       Impact factor: 10.122

Review 8.  Overweight, obesity, and cancer risk.

Authors:  France Bianchini; Rudolf Kaaks; Harri Vainio
Journal:  Lancet Oncol       Date:  2002-09       Impact factor: 41.316

Review 9.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.

Authors:  Daniel Q Huang; Hashem B El-Serag; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-21       Impact factor: 46.802

10.  Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMC Endocr Disord       Date:  2020-01-20       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.